[HTML][HTML] Low dose lung radiotherapy for COVID-19 pneumonia: A potential treatment
S Gupta, R Ahuja, N Sharma, P Singh, S Verma… - Respiratory …, 2021 - Elsevier
The covid-19 pandemic has been affecting many countries across the world and lost
precious lives. Most patients suffer from respiratory disease which progresses to the severe …
precious lives. Most patients suffer from respiratory disease which progresses to the severe …
Recent Advances in the Development of novel inhibitors targeting RNA Helicase Enzyme of SARS-CoV-2
R Satpathy, S Acharya - Journal of Biochemical Technology, 2023 - jbiochemtech.com
The rapid spread and infection rate of novel severe acute respiratory syndrome coronavirus
(SARS-CoV-2) has created a worldwide pandemic since its origin in 2019. Another concern …
(SARS-CoV-2) has created a worldwide pandemic since its origin in 2019. Another concern …
Guide to Diagnosis and Treatment of Acute Pneumonia in Children
AN Csep, F Marc, F Voiță-Mekereș… - Archives of Pharmacy …, 2024 - archivepp.com
By definition, inflammation of the lung parenchyma is called pneumonitis, and if the cause of
that inflammation is a microbial agent, it is called pneumonia. Microbial agents can be …
that inflammation is a microbial agent, it is called pneumonia. Microbial agents can be …
Prevalence of Malaria Among COVID-19, Exhibit Severity, Management, and Outcome
MA Motkhatr, MM Khier, SK Mohamed… - …, 2023 - pharmacophorejournal.com
Coronavirus disease-2019 (COVID-19) is an infectious disease caused by a new
coronavirus strain [1]. COVID-19 causes mild to moderate respiratory disease, many patients …
coronavirus strain [1]. COVID-19 causes mild to moderate respiratory disease, many patients …